Merrimack Pharmaceuticals (MACK) Soars: Stock Adds 7.4% is Session - Tale of the Tape

Merrimack Pharmaceuticals, Inc. (MACK) was a big mover last session, as its shares rose over7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $29.77 to $33.92 in the past one-month time frame.

In the last 30 days, the company did not witness any estimate revision while the Zacks Consensus Estimate moved lower, suggesting trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher lasts.

Merrimack Pharmaceuticals currently has a Zacks Rank #2 (Buy) while its Earnings ESP is positive.

Some other well-performing stocks worth considering in the med-biomed gene industry include Cambrex Corporation. (CBM), Gilead Sciences Inc. (GILD) and InSite Vision Incorporated (INSV). All these stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
MERRIMACK PHAR (MACK): Free Stock Analysis Report
 
INSITE VISION (INSV): Get Free Report
 
CAMBREX CORP (CBM): Free Stock Analysis Report
 
GILEAD SCIENCES (GILD): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research